About Agendia
Agendia is a company based in Irvine (United States) founded in 2003 by Laura van 't Veer.. Agendia has raised $123 million across 7 funding rounds from investors including ING, Debiopharm and European Union. Agendia offers products and services including MammaPrint and BluePrint. Agendia operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Irvine, United States
- Founders Laura van 't Veer
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Agendia, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$123 M (USD)
in 7 rounds
-
Latest Funding Round
$4.7 M (USD), Grant
Dec 31, 2018
-
Investors
ING
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Agendia
Agendia offers a comprehensive portfolio of products and services, including MammaPrint and BluePrint. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assesses breast cancer recurrence risk using genomic analysis.
Determines molecular subtyping of breast cancer tumors for treatment guidance.
Unlock access to complete
Unlock access to complete
Funding Insights of Agendia
Agendia has successfully raised a total of $123M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $4.7 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $4.7M
- First Round First Round
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Grant - Agendia | Valuation |
investors |
|
| Jul, 2018 | Amount | Series F - Agendia | Valuation | Athyrium Capital Management |
|
| Oct, 2015 | Amount | Grant - Agendia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Agendia
Agendia has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include ING, Debiopharm and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location | |
|
Life-Sciences & Offline focused VC firm funding companies in Netherlands
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Agendia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Agendia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Agendia Comparisons
Competitors of Agendia
Agendia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Agendia
When was Agendia founded?
Agendia was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Where is Agendia located?
Agendia is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Is Agendia a funded company?
Agendia is a funded company, having raised a total of $123M across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.01M, raised on Dec 26, 2005.
What does Agendia do?
Founded in 2003 and based in Irvine, United States, genomic diagnostic products for oncology are developed and supplied by Agendia. Breast cancer and solid tumors are analyzed through the flagship MammaPrint test. Tumor genes are subtyped into Luminal, HER2, and Basal categories via the BluePrint molecular test. Clinical trials in oncology are supported by the FLEX platform and I-SPY2 initiative.
Who are the top competitors of Agendia?
Agendia's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Agendia offer?
Agendia offers MammaPrint and BluePrint.
Who are Agendia's investors?
Agendia has 11 investors. Key investors include ING, Debiopharm, European Union, AXA Investment Managers, and Athyrium Capital Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.